PDZ domain-mediated protein interactions: Therapeutic targets in neurological disorders

Current Medicinal Chemistry

Volumn 21, Issue 23, 2014, Pages 2632-2641

  Khan, Z ^a,b,c   Lafon, M ^a,b  

^a INSTITUT PASTEUR   (France)

^b Institut Pasteur   (France)

^c INSTITUT CURIE   (France)

Author keywords

AMPA receptors; Microtubule associated serine threonine protein 2 (MAST2); NMDA receptors; PBMs; PDZ domain; PSD95 family proteins; Rabies virus

Indexed keywords

ION CHANNEL; MAST 2 PROTEIN; PDZ PROTEIN; PEPTIDE; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN; RECEPTOR; UNCLASSIFIED DRUG; LIGAND; PROTEIN BINDING;

ARTICLE; HUMAN; NERVE CELL; NERVE CELL PLASTICITY; NERVOUS SYSTEM; NEUROLOGIC DISEASE; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; NERVOUS SYSTEM DISEASES; PDZ DOMAIN;

ANIMALS; HUMANS; LIGANDS; MODELS, MOLECULAR; NERVOUS SYSTEM DISEASES; PDZ DOMAINS; PROTEIN BINDING; PROTEINS;

EID: 84903720808     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867321666140303145312     Document Type: Article

References (107)

1. Ponting, C.P. Evidence for PDZ domains in bacteria, yeast, and plants. Protein Sci., 1997, 6, 464-468.
2. Belotti, E.; Polanowska, J.; Daulat, A.M.; Audebert, S.; Thome, V.; Lissitzky, J.C.; Lembo, F.; Biblek, K.; Omi, S.; Lenfant, N.; Gangar, A.; Montcouquiol, M.; Santoni, M.J.; Sebbagh, M.; Aurrand-Lions, M.; Angers, S.; Kodjabachian, L.; Reboul, J.; Borg, J.P. The human PDZome: a gateway to PDZ mediated functions. Mol. Cell. Proteomics, 2013, 12, 2587-25603.
3. Scott, J.D.; Pawson, T. Cellsignaling in space and time: whereproteinscometogether and when they'reapart. Science, 2009, 326(5957), 1220-1224.
4. Pawson, T.; Kofler, M. Kinome signaling through regulated protein-protein interactions in normal and cancer cells. Curr. Opin. Cell. Biol., 2009, 21(2), 147-153.
5. Letunic, I.; Doerks, T.; Bork, P.SMART 7: recent updates to the protein domain annotation resource. Nucl. Acids Res., 2012, 40, 302-305.
6. Kim, E.; Sheng, M. PDZ domain proteins of synapses. Nat. Rev. Neurosci., 2004, 10, 771-781.
7. Vogrig, A.; Dorr, L.; Bouzidi,; N.; Boucherle, B.; Wattiez, A.S.; Cassier, E.; Vallon, G.; Ripoche, I.; Abrunhosa-Thomas, I.; Marin, P.; Nauton, L.; Thery, V.; Courteix, C.; Lian, L.Y.; Ducki, S. Structure-Based Design of PDZ Ligands as Inhibitors of 5-HT2A Receptor / PSD-95 PDZ1 Domain Interaction Possessing Anti-Hyperalgesic Activity. ACS Chem. Biol., 2013, 8, 2209-2216.
8. Harris, B.Z.; Lim, W. A. Mechanism and role of PDZ domains in signaling complex assembly. J. Cell Sci., 2001, 114, 3219-3231.
9. Lee, H.J.; Zheng, J.J. PDZ domains and their binding partners: structure, specificity, and modification. Cell Commun. Signal., 2010, 8, 8.
10. Kim, E.; Niethammer, M.; Rothschild, A.; Jan, Y.N.; Sheng, M. Clustering of Shaker-type K+ channels by interaction with a family of membrane-associated guanylate kinases. Nature, 1995, 378, 85-88.
11. Bard, L.; Sainlos, M.; Bouchet, D.; Cousins, S.; Mikasova, L.; Breillat, C.; Stephenson, F.A.; Imperiali, B.; Choquet, D.; Groc, L. Dynamic and specific interaction between synaptic NR2-NMDA receptor and PDZ proteins. Proc. Natl. Acad. Sci. USA., 2010, 107(45), 19561-19566.
12. Ning, K.; Drepper, C.; Valori, C.F.; Ahsan, M.; Wyles, M.; Higginbottom, A.; Herrmann, T.; Shaw, P.; Azzouz, M.; Sendtner, M. PTEN depletion rescues axonal growth defect and improves survival in SMN-deficient motor neurons. Hum. Mol. Genet., 2010, 19(16), 3159-3168.
13. Valiente, M.; Andrés-Pons, A.; Gomar, B.; Torres, J.; Gil, A.; Tapparel, C.; Antonarakis, S.E.; Pulido, R. Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases. J. Biol. Chem., 2005, 280(32), 28936-28943.
14. Nourry, C.; Grant, S. G.; Borg, J. P. PDZ domain proteins: plug and play. Sci. STKE, 2003, 179, RE7.
15. Zhang, J.; Lewis, S.M.; Kuhlman, B.; Lee, A.L. Supertertiary structure of the MAGUK core from PSD-95. Structure, 2013, 21(3), 402-413.
16. Feng, W.; Zhang, M. Organization and dynamics of PDZ- domainrelatedsupramodules in the postsynaptic density. Nat. Rev. Neurosci., 2009, 10, 87-99.
17. Fanning, A.S.; Anderson, J.M. Protein modules as organizers of membrane structure. Curr. Opin. Cell. Biol., 1999, 11, 432-439.
18. Laskowski, R.A.; Chistyakov, V.V.; Thornton, J.M. PDBsum more: new summaries and analyses of the known 3D structures of proteins and nucleic acids. Nucleic Acids Res., 2005, 33, D266-D268.
19. Tochio, H.; Hung, F.; Li, M.; Bredt, D. S.; Zhang, M. Solution Structure and Backbone Dynamics of the Second PDZ Domain of Postsynaptic Density-95. J. Mol. Biol., 2000, 295, 225-237.
20. Daniels, D.L.; Cohen, A.R.; Anderson, J.M.; Brunger, A.T. Crystal structure of the hCASK PDZ domain reveals the structural basis of class II PDZ domain target recognition. Nat. Struct. Biol., 1998, 5, 317-325.
21. Hillier, B.J.; Christopherson, K.S.; Prehoda, K.E.; Bredt, D.S.; Lim, W.A. Unexpected modes of PDZ domain scaffolding revealed by structure of nNOS-syntrophin complex. Science, 1999, 284, 812-815.
22. Kozlov, G.; Gehring, K.; Ekiel, I. Solution structure of the PDZ2 domain from human phosphatase hPTP1E and its interactions with C-terminal peptides from the Fas receptor. Biochemistry, 2000, 39, 2572-2580.
23. Karthikeyan, S.; Leung, T.; Ladias, J.A. Structural basis of the Na+/H+ exchanger regulatory factor PDZ1 interaction with the carboxyl-terminal region of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem., 2001, 276, 19683-19686.
24. Kimple, M.E.; Siderovski, D.P.; Sondek, J. Functional relevance of the disulfide-linked complex of the N-terminal PDZ domain of InaD with NorpA. EMBO J., 2001, 20, 4414-4422.
25. Songyang, Z.; Fanning, A.S.; Fu, C.; Xu, J.; Marfatia, S.M.; Chishti, A.H.; Crompton, A.; Chan, A.C.; Anderson, J.M.; Cantley, L.C. Recognition of unique carboxyl-terminal motifs by distinct PDZ domains. Science, 1997, 275, 73-77.
26. Dev, K.K. Making protein interactions druggable: targeting PDZ domains. Nat. Rev. Drug Discov., 2004, 3(12), 1047-1056.
27. Babault, N.; Cordier, F.; Lafage, M.; Cockburn, J.; Haouz, A.; Prehaud, C.; Rey, F.A.; Delepierre, M.; Buc, H.; Lafon, M.; Wolff, N. Peptides targeting the PDZ domain of PTPN4 are efficient inducers of glioblastoma cell death. Structure, 2011, 19(10), 1518-1524.
28. Terrien, E.; Chaffotte, A.; Lafage, M.; Khan, Z.; Préhaud, C.; Cordier, F.; Simenel, C.; Delepierre, M.; Buc, H.; Lafon, M.; Wolff, N. Interference with the PTEN-MAST2 interaction by a viral protein leads to cellular relocalization of PTEN. Sci. Signal., 2012, 5(237), ra58.
29. Delury CP, Marsh E, James CD, Boon SS, Banks L, Knight GL, Roberts S. The role of protein kinase A regulation of the E6 PDZbinding domain during the differentiation-dependent life cycle of human papillomavirus type 18. J. Virol., 2013, 87(17), 9463-9472.
30. Kim, J.H.; Huganir, R.L. Organization and regulation of proteins at synapses. Curr. Opin. Cell. Biol., 1999, 11(2), 248-254.
31. Craven, S.E.; Bredt, D.S. PDZ proteins organize synaptic signaling pathways. Cell, 1998, 93, 495-498.
32. Lu, W.; Ziff, E.B. PICK1 interacts with ABP/GRIP to regulate AMPA receptor trafficking. Neuron., 2005, 47(3), 407-421.
33. Ehlers, M.D.; Mammen, A.L.; Lau, L.F.; Huganir, R.L. Synaptic targeting of glutamate receptors. Curr. Opin. Cell. Biol., 1996, 8, 484-489.
34. Hall, Z.; Sanes, J. Synaptic structure and development: the neuromuscular junction. Cell Neuron., 1993, 72, 99-121.
35. Garner, C.C.; Kindler, S. Synaptic proteins and the assembly of synaptic junctions. Trends Cell Biol., 1996, 6, 429-433.
36. Pawson, T.; Scott, J.D. Signaling through scaffold, anchoring, and adaptor proteins. Science, 1997, 278, 2075-2080.
37. Ziff, E.B. Enlightening the postsynaptic density. Neuron, 1997, 19, 1163-1174.
38. Garner, C.C.; Nash, J.; Huganir, R.L. PDZ domains in synapse assembly and signaling. Trends Cell Biol., 2000, 10, 274-280.
39. Long, J. F.; Tochio, H.; Wang, P.; Fan, J.S.; Sala, C.; Niethammer, M.; Sheng, M.; Zhang, M. Supramodular structure and synergistic target binding of the N-terminal tandem PDZ domains of PSD-95. J. Mol. Biol., 2003, 327, 203-214.
40. Hsueh, Y. P.; Sheng, M. Requirement of N-terminal cysteines of PSD-95 for PSD-95 multimerization and ternary complex formation, but not for binding to potassium channel Kv1.4. J. Biol. Chem., 1999, 274, 532-536.
41. Roche, K. W.; Standley, S.; McCallum, J.; Ly, C.D.; Ehlers, M.D.; Wenthold, R.J. Molecular determinants of NMDA receptor internalization. Nat. Neurosci., 2001, 4, 794-802.
42. Jugloff, D. G.; Khanna, R.; Schlichter, L. C.; Jones, O. T. Internalization of the Kv1.4 potassium channel is suppressed by clustering interactions with PSD-95. J. Biol. Chem., 2000, 275(2), 1357-1364.
43. Gramates, L. S.; Budnik, V. Assembly and maturation of the Drosophila larval neuromuscular junction. Int. Rev. Neurobiol., 1999, 43, 93-117.
44. Lim, I.A.; Merrill, M.A.; Chen, Y.; Hell, J.W. Disruption of the NMDA receptor-PSD-95 interaction in hippocampal neurons with no obvious physiological short-term effect. Neuropharmacology, 2003, 45(6), 738-754.
45. Chen, H.J.; Rojas-Soto, M.; Oguni, A.; Kennedy, M.B. A synaptic Ras-GTPase activating protein (p135 SynGAP) inhibited by CaM kinase II. Neuron, 1998, 20, 895-904.
46. Kim, J.H.; Liao, D.; Lau, L.F.; Huganir, R.L. SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family. Neuron, 1998, 20, 683-691.
47. Kim, E.; Naisbitt, S.; Hsueh, Y.P.; Rao, A.; Rothschild, A.; Craig, A.M.; Sheng, M. GKAP, a novel synaptic protein that interacts with theguanylate kinase-like domain of the PSD-95/SAP90 family of channel clustering molecules. J. Cell Biol., 1997, 136, 669-678.
48. Takeuchi, M.; Hata, Y.; Hirao, K.; Toyoda, A.; Irie, M.; Takai, Y. SAPAPs. A family of PSD-95/SAP90-associated proteins localized atpostsynaptic density. J. Biol. Chem., 1997, 272, 11943-11951.
49. Dong, H.; O'Brien, R.J.; Fung, E.T.; Lanahan, A.A.; Worley, P.F.; Huganir, R.L. GRIP: a synaptic PDZ domain-containing protein that interacts with AMPA receptors. Nature, 1997, 386, 279-284.
50. Srivastava, S.; Osten, P.; Vilim, F.S.; Khatri, L.; Inman, G.; States, B.; Daly, C.; DeSouza, S.; Abagyan, R.; Valtschanoff J.G.; Weinberg, R. J.; Ziff, E. B.Novel anchorage ofGluR2/3 to the postsynaptic density by the AMPA receptor binding protein ABP. Neuron, 1998, 21, 581-591.
51. Hanley, L.J.; Henley, J.M. Differential roles of GRIP1a and GRIP1b in AMPA receptortrafficking. Neurosci. Lett., 2010, 485(3), 167-172.
52. Xia, J.; Zhang, X.; Staudinger, J.; Huganir, R.L. Clustering of AMPA receptors by the synaptic PDZ domain containing protein PICK1. Neuron, 1999, 22, 179-187.
53. Irie, M.; Hata, Y.; Takeuchi, M.; Ichtchenko, K.; Toyoda, A.; Hirao, K.; Takai, Y.; Rosahl, T.W.; Sudhof, T.C. Binding of neuroligins to PSD-95. Science, 1997, 277, 1511-1515.
54. Ichtchenko, K.; Hata, Y.; Nguyen, T.; Ullrich, B.; Missler, M.; Moomaw, C.; Sudhof, T.C. Neuroligin 1: a splice site-specific ligand for betaneurexins. Cell, 1995, 81, 435-443.
55. Li, Z.; Sheng, M. Some assembly required: the development of neuronal synapses. Nat. Rev. Mol. Cell Biol., 2003, 4, 833-841.
56. Hata, Y.; Butz, S.; Sudhof, T.C. CASK: a novel dlg/PSD95 homolog with an N-terminal calmodulin-dependent protein kinase domain identified by interaction with neurexins. J. Neurosci., 1996, 16, 2488-2494.
57. Okamoto, M.; Sudhof, T.C. Mints, Munc18-interacting proteins in synaptic vesicle exocytosis. J. Biol. Chem., 1997, 272, 31459-31464.
58. Butz, S.; Okamoto, M.; Sudhof, T.C. A tripartite protein complex withthe potential to couple synaptic vesicle exocytosis to cell adhesion in brain. Cell, 1998, 94, 773-782.
59. Garland, P.; Quraishe, S.; French, P.; O'Connor, V. Expression of the MAST family of serine/threonine kinases. Brain Res., 2008, 1195, 12-19.
60. Lumeng, C.; Phelps, S.; Crawford, G.E.; Walden, P.D.; Barald, K.; Chamberlain, J.S. Interactions between beta 2-syntrophin and a family of microtubule-associated serine/threonine kinases. Nat. Neurosci., 1999, 2(7), 611-617.
61. Loh, S.H.; Francescut, L.; Lingor, P.; Bähr, M.; Nicotera, P. Identification of new kinase clusters required for neurite outgrowth and retraction by a loss-of-function RNA interference screen. Cell. Death Differ., 2008, 15(2), 283-298.
62. Neurological Disorders: public health challenges. WHO 2006, ISBN 92 4 156336 2; ISBN 978 92 4 156336 9; (NLM classifi cation: WL 140)
63. Gandhi, P.; Khan, Z.; Bhadoria, P.; Gupta, R.; Saha, N.K.; Bisen, P.S. Origin and Expansion of Trinucleotide Repeats and Neurological Disorders. Curr. Genomics, 2005, 6, 563-568.
64. Gardiol, D. PDZ-containing proteins as targets in human pathologies. FEBS J., 2012, 279(19), 3529.
65. Mo, J.; Choi, S.; Ahn, P.G.; Sun, W.; Lee, H.W.; Kim, H. PDZscaffold protein, Tamalin promotes dendritic outgrowth and arborization in rat hippocampal neuron. Biochem. Biophys. Res. Commun., 2012, 422(2), 250-255.
66. Barnes, G.N.; Slevin, J.T. Ionotrpoic glutamate receptor biology: effect on synaptic connectivity and function in neurological disease. Curr. Med. Chem., 2003, 10, 2059-2072.
67. Collingridge, G.L.; Isaac, J.T. Functional roles of protein interactions with AMPA and kainate receptors. Neurosci. Res., 2003, 47, 3-15.
68. Griffin, R.J.; Moloney, A.; Kelliher, M.; Johnston, J.A.; Ravid, R.; Dockery, P.; O'Connor, R.; O'Neill, C. Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology. J. Neurochem., 2005, 93, 105-117.
69. Chang, N.; El-Hayek, Y.H.; Gomez, E.; Wan, Q. PhosphatasePTEN in neuronalinjury and brain disorders. Trends Neurosci., 2007, 30(11), 581-586.
70. Aarts, M.; Liu, Y.; Liu, L.; Besshoh, S.; Arundine, M.; Gurd, J.W.; Wang, Y.T.; Salter, M.W.; Tymianski, M. Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions. Science, 2002, 298(5594), 846-850.
71. Hou, S.W.; Zhi, H.Y.; Pohl, N.; Loesch, M.; Qi, X.M.; Li, R.S.; Basir, Z.; Chen, G. PTPH1 dephosphorylates and cooperates with p38gamma MAPK to increase rasoncogenesis through PDZmediated interaction. Cancer Res., 2010, 70, 2901-2910.
72. Jeleń, F.; Oleksy, A.; Smietana, K.; Otlewski, J. PDZ domains-common players in the cell signaling. Acta Biochim. Pol., 2003, 50(4), 985-1017.
73. Lamprecht, G.; Seidler, U. The emerging role of PDZ adapter proteins for regulation of intestinal ion transport. Am. J. Physiol. Gastrointest. Liver Physiol., 2006, 291(5), 766-777.
74. Volkmer, R.; Tapia, V.; Landgraf, C. Synthetic peptide arrays for investigating protein interaction domains. FEBS Lett., 2012, 586, 2780-2786.
75. Chen, X.; Longgood, J.C.; Michnoff, C.; Wei, S.; Frantz, D.E.; Bezprozvanny, L. Highthroughput screen for small molecule inhibitors of Mint1-PDZ domains. Assay Drug Dev. Technol., 2007, 5, 769-783.
76. Fujii, N.; You, L.; Xu, Z.; Uematsu, K.; Shan, J.; He, B.; Mikami, I.; Edmondson, L.R.; Neale, G.; Zheng, J.; Guy, R.K.; Jablons, D.M. An antagonist of dishevelled protein-protein interaction suppresses beta-catenin-dependent tumor cell growth. Cancer Res., 2007, 67, 573-579.
77. Mayasundari, A.; Ferreira, A.M.; He, L.; Mahindroo, N.; Bashford, D.; Fujii, N. Rational design of the first small-molecule antagonists of NHERF1/EBP50 PDZ domains. Bioorg. Med. Chem. Lett., 2008, 18, 942-945.
78. Toogood, P.L. Inhibition of protein-protein association by small molecules: approaches and progress. J. Med. Chem., 2002, 45, 1543-1558.
79. Osten, P.;Khatri, L.; Perez, J.L.; Köhr, G.; Giese, G.; Daly, C.; Schulz, T.W.; Wensky, A.; Lee, L.M.; Ziff. E.B. Mutagenesis reveals a role for ABP/GRIP binding to GluR2 in synaptic surface accumulation of the AMPA receptor. Neuron, 2000, 27, 313-325.
80. Novak, K.A.P. ; Fujii, N.; Guy, R.K. Investigation of the PDZ domain ligand binding site using chemically modified peptides. Bioorg. Med. Chem. Lett., 2002, 12, 2471-2474.
81. Roberts, K.E.; Cushing, P.R.; Boisguerin, P.; Madden, D.R.; Donald, B.R. Computational Design of a PDZ Domain Peptide Inhibitor that Rescues CFTR Activity. PLoS Comput. Biol., 2012, 8(4), e1002477.
82. Grandy, D.; Shan, J.; Zhang, X.; Rao, S.; Akunuru, S.; Li, H.; Zhang, Y.; Alpatov, I.; Zhang, X.A.; Lang, R.A.; Shi, D.L.; Zheng, J.J. Discovery and Characterization of a Small Molecule Inhibitor of the PDZ Domain of Dishevelled Received for publication. J. Biol. Chem., 2009, 284(24), 16256-16263.
83. Daw, M.I.; Chittajallu, R.; Bortolotto, Z.A.; Dev, K.K.; Duprat, F.; Henley, J.M.; Collingridge, G.L.; Isaac, J.T. PDZ proteins interacting with C-terminal GluR2/3 are involved in a PKC-dependent regulation of AMPA receptors at hippocampal synapses. Neuron, 2000, 28, 873-886.
84. Volk, L.; Kim, C.H.; Takamiya, K.; Yu, Y.; Huganir, R.L. Developmental regulation of protein interacting with C kinase 1 (PICK1) function in hippocampal synaptic plasticity and learning. Proc. Natl. Acad. Sci. USA., 2010, 107, 21784-21789.
85. Steinberg, J.P.; Takamiya, K.; Shen, Y.; Xia, J.; Rubio, M.E.; Yu, S.; Jin, W.; Thomas, G.M.; Linden, D.J.; Huganir, R.L. Targeted in vivo mutations of the AMPA receptor subunit GluR2 and its interacting protein PICK1 eliminate cerebellar long-term depression. Neuron, 2006, 49, 845-860.
86. Thorsen, T.S.; Madsen, K.L.; Rebola, N.; Rathje, M.; Anggono, V.; Bach, A.; Moreira, I.S.; Stuhr-Hansen, N.; Dyhring, T.; Peters, D.; Beuming, T.; Huganir, R.; Weinstein, H.; Mulle, C.; Strømgaard, K.; Rønn, L.C.; Gether, U. Identification of a small-molecule inhibitor of the PICK1 PDZ domain that inhibits hippocampal LTP and LTD. Proc. Natl. Acad. Sci. USA., 2010, 107, 413-418.
87. Dawson, V.L.; Dawson, T.M.; London, E.D.; Bredt, D.S.; Snyder, S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA., 1991, 88, 6368-6371.
88. Huang, Z.; Huang, P.L.; Panahian, N.; Dalkara, T.; Fishman, M.C.; Moskowitz, M.A. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science, 1994, 265, 1883-1885.
89. Soriano, F.X.; Martel, M.A.; Papadia, S.; Vaslin, A.; Baxter, P.; Rickman, C.; Forder, J.; Tymianski, M.; Duncan, R.; Aarts, M.; Clarke, P.; Wyllie, D.J.; Hardingham, G.E. Specific targeting of pro-death NMDA receptor signals with differing reliance on the NR2B PDZ ligand. J. Neurosci., 2008, 28, 10696-10710.
90. Tymianski, M. Emerging mechanisms of disrupted cellular signaling in brain ischemia. Nat. Neurosci., 2011, 14, 1369-1373.
91. Tao, F.; Su, Q.; Johns, R.A. Cell-permeable peptide Tat-PSD-95 PDZ2 inhibits chronic inflammatory pain behaviors in mice. Mol. Ther., 2008, 16, 1776-1782.
92. Ittner, L.M.; Ke, Y.D.; Delerue, F.; Bi, M.; Gladbach, A.; van Eersel, J.; Wölfing, H.; Chieng, B.C.; Christie, M.J.; Napier, I.A.; Eckert, A.; Staufenbiel, M.; Hardeman, E.; Götz, J. Dendritic function of tau mediates amyloid- toxicity in Alzheimer's disease mouse models. Cell, 2010, 142, 387-397.
93. LeBlanc, B.W.; Iwata, M.; Mallon, A.P.; Rupasinghe, C.N.; Goebel, D.J.; Marshall, J.; Spaller, M.R.; Saab, C.Y. A cyclic peptide targeted against PSD-95 blocks central sensitization and attenuates thermal hyperalgesia. Neuroscience, 2010, 167, 490-500.
94. D'Mello, R.; Marchand, F.; Pezet, S.; McMahon, S. B.; Dickenson, A. H. Perturbing PSD-95 interactions with NR2B-subtype receptors attenuates spinal nociceptive plasticity and neuropathic pain. Mol. Ther., 2011, 19, 1780-1792.
95. Florio, S.K.; Loh, C.; Huang, S.M.; Iwamaye, A.E.; Kitto, K.F.; Fowler, K.W.; Treiberg, J. A.; Hayflick, J. S.; Walker, J. M.; Fairbanks, C. A.; Lai, Y. Disruption of nNOS-P SD95 protein-protein interaction inhibits acute tehrmal hyperalgesia and chronic mechanical allodyniain rodents. Br. J. Pharmacol., 2009, 158, 494-506.
96. Hong-Shuo, S.; Doucette, T. A.; Liu, Y.; Fang, Y.; Teves, L.; Aarts, M.; Ryan, C. L.; Bernard, P. B.; Lau, A.; Forder, J. P.; Salter, M. W.; Wang, Y. T.; Tasker, R. A.; Tymianski, M. Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat. Stroke, 2008, 39, 2544-2553.
97. Tat-NR2B9c is found under the name NA-1 at www.clinicaltrials. gov.
98. Bach, A.; Clausenb, B.H.; Møllera, M.; Vestergaarda, B.; Chic, C.N.; Roundd, A.; Sørensena, P.L., Nissena, K.B.; Kastrupa, J.S.; Gajhedea, M.; Jemthc, P.; Kristensena, A.S.; Lundströme, P.; Lambertsenb, K.L.; Strømgaarda, K. High-affinity, dimeric inhibitor of PSD-95 bivalently interacts with PDZ1-2 and protects against ischemic brain damage. Proc. Natl. Acad. Sci. U.S.A., 2012, 109(9), 3317-3322.
99. Tomaić, V.;Gardiol, D.; Massimi, P.; Ozbun, M.; Myers, M.; Banks, L. Human and primate tumour viruses use PDZ binding as an evolutionarily conserved mechanism of targeting cell polarity regulators. Oncogene, 2009, 28, 1-8.
100. Golebiewski, L.; Liu, H.; Javier, R.T.; Rice, A.P. The avian influenza virus NS1 ESEV PDZ binding motif associates with Dlg1 and Scribble to disrupt cellular tight junctions. J Virol., 2011, 85(20),10639-10648.
101. Nguyen, M.L.; Nguyen, M.M.; Lee, D.; Griep, A.E.; Lambert, P.F. The PDZ Ligand Domain of the Human Papillomavirus Type 16 E6 Protein Is Required for E6's Induction of Epithelial Hyperplasia In Vivo. J. Virol., 2003, 77, 6957-6964.
102. Tsubata, C.; Higuchi, M.; Takahashi, M.; Oie, M.; Tanaka, Y.; Gejyo, F.; Fujii, M. PDZ domain-binding motif of human T-cell leukemia virus type 1 Tax oncoprotein is essential for the interleukin 2 independent growth induction of a T-cell line. Retrovirology, 2005, 2, 46.
103. Préhaud, C.; Wolff, N.; Terrien, E.; Lafage, M.; Mégret, F.; Babault, N.; Cordier, F.; Tan, G.S.; Maitrepierre, E.; Ménager, P.; Chopy, D.; Hoos, S.; England, P.; Delepierre, M.; Schnell, M.J.; Buc, H., Lafon, M. Attenuation of rabies virulence: takeover by the cytoplasmic domain of its envelope protein. Sci. Signal., 2010, 3(105), ra5.
104. Javier, R.T.; Rice, A.P. Emerging theme: cellular PDZ proteins as common targets of pathogenic viruses. J. Virol., 2011, 85(22), 11544-11556.
105. Lafon, M. Evasive strategies in rabies virus infection. Adv. Virus Res., 2011, 79, 33-53.
106. Prehaud, C.; Lafon, M.; Schnell, M.J. Neuron Generation, Regeneration and Protection, International Patent 2010: WO2010116258.
107. Schultz, J.; Milpetz, F.; Bork, P.; Ponting, C.P. SMART, a simple modular architecture research tool: identification of signaling domains. Proc. Natl. Acad. Sci. USA., 1998, 95, 5857-5864.